Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities.
Antimicrob Agents Chemother
; 60(3): 1695-701, 2015 Dec 28.
Article
en En
| MEDLINE
| ID: mdl-26711777
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Pironas
/
Enfermedades Cutáneas Infecciosas
/
Infecciones Estafilocócicas
/
Benzofuranos
/
Enoil-ACP Reductasa (NADH)
/
Staphylococcus aureus Resistente a Meticilina
/
Antibacterianos
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Antimicrob Agents Chemother
Año:
2015
Tipo del documento:
Article
País de afiliación:
Canadá